What are the characteristics of a T4 (Tumor, Node, Metastasis) classification for breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

T4 Breast Cancer Classification

T4 breast cancer is defined as a tumor of any size with direct extension to the chest wall and/or skin involvement (ulceration or skin nodules), and is subdivided into four distinct categories: T4a (chest wall extension), T4b (skin ulceration/satellite nodules/edema), T4c (both T4a and T4b), and T4d (inflammatory carcinoma). 1

T4 Subcategories

T4a: Chest Wall Extension

  • Extension to the chest wall, specifically excluding pectoralis muscle adherence or invasion alone 1
  • The chest wall includes the ribs, intercostal muscles, and serratus anterior muscle 1
  • Pectoralis muscle involvement by itself does not qualify as T4a 1

T4b: Skin Involvement (Non-Inflammatory)

  • Ulceration of the skin and/or ipsilateral satellite skin nodules and/or edema (including peau d'orange) of the skin 1
  • These findings must be clinically evident and do not meet criteria for inflammatory carcinoma 1, 2
  • Important caveat: Nipple retraction is explicitly excluded from T4b classification 2
  • Dimpling of the skin or nipple retraction may occur in T1, T2, or T3 tumors without changing their classification 2
  • Nipple retraction represents secondary skin change from tumor traction or fibrosis, not the aggressive skin involvement that characterizes T4b disease 2

T4c: Combined Features

  • Both T4a and T4b features present simultaneously 1

T4d: Inflammatory Carcinoma

  • Inflammatory carcinoma, which is a distinct clinicopathologic entity 1
  • This represents the most aggressive form of T4 disease 3
  • Characterized by diffuse erythema and edema (peau d'orange) involving at least one-third of the breast skin 3

Critical Clinical Distinctions

Size Independence

  • T4 classification is independent of tumor size 1
  • A tumor can be very small (even <3 cm) and still be classified as T4 if it meets the skin or chest wall involvement criteria 4
  • Small T4 tumors (≤3 cm) may have better prognosis than larger T4 tumors, with 5-year survival of 71.3% versus 34.7% 4

Staging Implications

  • T4 disease corresponds to Stage III breast cancer when combined with appropriate N and M classifications 3
  • Stage IIIB specifically includes T4N0-2M0, representing inoperable locally advanced disease 3
  • Any T4 tumor with N2-N3 nodal involvement or any T with N3 involvement constitutes Stage IIIC disease 3

Common Pitfalls to Avoid

Do not classify nipple retraction or simple skin dimpling as T4b 2

  • These secondary skin changes should prompt staging based on actual tumor size (T1-T3) 2

Do not confuse pectoralis muscle invasion with chest wall extension 1

  • Pectoralis muscle adherence or invasion alone does not qualify as T4a 1

Distinguish T4b from T4d carefully 1

  • T4b has localized skin findings that do not meet inflammatory carcinoma criteria 1
  • T4d requires the full clinical picture of inflammatory breast cancer 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Breast Cancer Staging Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

TNM Classification and Management of Locally Advanced Breast Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.